Adding Multimedia FDA Approves Herceptin For HER2-Positive Metastatic Stomach...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced the U.S. Food and Drug Administration (FDA) has approved Herceptin® (trastuzumab) in combination with chemotherapy...
View ArticleNICE Consults Again On Appraisal Of Bevacizumab For The Treatment Of...
NICE is issuing a second consultation document as part of its appraisal of bevacizumab (Avastin) in combination with chemotherapy (oxaliplatin and either 5-fluorouracil or capecitabine) for treating...
View ArticleBevacizumab For Treating Metastatic Colorectal Cancer: Benefits For Some...
NICE has published final draft guidance as part of its appraisal of bevacizumab (Avastin) in combination with chemotherapy (oxaliplatin and either 5-fluorouracil or capecitabine) for treating...
View ArticleNICE Publishes Appeal Decision On Lapatinib
The National Institute for Health and Clinical Excellence (NICE) has published the outcome of an appeal hearing relating to its draft guidance on the use of lapatinib (Tyverb, GlaxoSmithKline) for...
View ArticleJournal of Clinical Oncology Publishes Phase 2 Clinical Trial Results of...
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) (the “Company”) today announced that a manuscript entitled “Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine as Second- or...
View Article
